GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Dr Reddys Laboratories Ltd
Dr Reddy's Board Approves Q2 FY27 Unaudited Financial Results
BOARD ▲ Positive Development LOW RISK
📅 Filed on BSE: 23 Oct 2026, 06:39 PM IST  ·  BSE ID: b6812dc4-3633-42cf-8016-893af8b08dd9
View Original BSE Filing (PDF)
💡
In Simple Terms
Dr Reddy's Board reviewed and approved its latest financial results and made a management appointment.
🤖 AI Summary
  • Board approved unaudited financial results for Q2 and H1 FY27.
  • Results prepared under IFRS and Indian Accounting Standards (Ind AS).
  • Statutory Auditors provided limited review reports on the results.
  • Mr. Akhil Ravi appointed as Senior Management Personnel.
  • Nomination, Governance and Compensation Committee recommended the appointment.
🏢 How This Affects the Company
📈
Business Impact
Disclosure of financial performance for the period, providing transparency on the company's operational results.
💰
Financial Impact
The announced results will provide stakeholders with updated figures on revenue, profitability, and other key financial metrics for the specified periods.
⚙️
Operational Impact
Appointment of Mr. Akhil Ravi as Senior Management Personnel suggests a change in leadership or key personnel within the company's operational structure.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders. Shareholders can review the released financial results.
👤
Who Is Affected
All shareholders are affected by the disclosure of the company's financial performance and management changes.
🔍
Management Signal
The board's regular approval of financial results and a senior management appointment signals adherence to governance and operational continuity.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Detailed financial report release for Q2 FY27.
Subsequent quarterly results announcements.
Company announcements regarding Mr. Ravi's role.
LOW RISK Routine board meeting outcome with standard financial result disclosures.
💡 Investor Takeaway
Dr Reddy's Board approved unaudited Q2 and H1 FY27 financial results, prepared per IFRS and Ind AS, and appointed Mr. Akhil Ravi as Senior Management Personnel.
❓ Frequently Asked Questions
What did the Dr Reddy's Board of Directors approve on October 23, 2026?
The Board approved the unaudited financial results for the quarter and half-year ended September 30, 2026, and the appointment of Mr. Akhil Ravi as Senior Management Personnel.
Which financial standards were used for Dr Reddy's Q2 FY27 results?
The results were prepared in compliance with International Financial Reporting Standards (IFRS) and Indian Accounting Standards (Ind AS).
Who recommended the appointment of Mr. Akhil Ravi at Dr Reddy's?
The Nomination, Governance and Compensation Committee, along with the Audit Committee, recommended the appointment of Mr. Akhil Ravi.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.